Literature DB >> 34671572

A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination.

Yash Kripalani1, Vidyadhara Lakkappan1, Lipeeka Parulekar2, Anjum Shaikh1, Rakesh Singh3, Pradeep Vyas1.   

Abstract

Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. Their emergency administration in healthcare settings has been accompanied by numerous adverse effects. A case of Guillain-Barré syndrome following vaccination with Covishield is presented here to highlight this possible adverse condition. LEARNING POINTS: Guillain-Barré Syndrome (GBS) is a very rare complication after vaccination against SARS-CoV-2.The key concepts related to the understanding, management and outcomes of patients with GBS are discussed. © EFIM 2021.

Entities:  

Keywords:  AstraZeneca; ChAdOx1; Covishield; GBS; Guillain-Barré syndrome; coronavirus; pandemic; vaccine

Year:  2021        PMID： 34671572      PMCID： PMC8523377          DOI： 10.12890/2021_002797

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN： 2284-2594


  11 in total

Review 1.  Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.

Authors:  Claudia Vellozzi; Shahed Iqbal; Karen Broder
Journal:  Clin Infect Dis       Date:  2014-01-09       Impact factor: 9.079

2.  Guillain-Barré Syndrome following ChAdOx1-S/nCoV-19 Vaccine.

Authors:  Boby V Maramattom; Parameswaran Krishnan; Reji Paul; Sandeep Padmanabhan; Soumya Cherukudal Vishnu Nampoothiri; Akheel A Syed; Halinder S Mangat
Journal:  Ann Neurol       Date:  2021-06-22       Impact factor: 10.422

3.  Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Authors:  Jordan R Barrett; Sandra Belij-Rammerstorfer; Christina Dold; Katie J Ewer; Pedro M Folegatti; Ciaran Gilbride; Rachel Halkerston; Jennifer Hill; Daniel Jenkin; Lisa Stockdale; Marije K Verheul; Catherine M Green; Adrian V S Hill; Teresa Lambe; Sarah Gilbert; Andrew J Pollard; Parvinder K Aley; Brian Angus; Duncan Bellamy; Eleanor Berrie; Sagida Bibi; Mustapha Bittaye; Miles W Carroll; Breeze Cavell; Elizabeth A Clutterbuck; Nick Edwards; Amy Flaxman; Michelle Fuskova; Andrew Gorringe; Bassam Hallis; Simon Kerridge; Alison M Lawrie; Aline Linder; Xinxue Liu; Meera Madhavan; Rebecca Makinson; Jack Mellors; Angela Minassian; Maria Moore; Yama Mujadidi; Emma Plested; Ian Poulton; Maheshi N Ramasamy; Hannah Robinson; Christine S Rollier; Rinn Song; Matthew D Snape; Richard Tarrant; Stephen Taylor; Kelly M Thomas; Merryn Voysey; Marion E E Watson; Daniel Wright; Alexander D Douglas
Journal:  Nat Med       Date:  2020-12-17       Impact factor: 53.440

4.  Exacerbating Guillain-Barré Syndrome Eight Days after Vector-Based COVID-19 Vaccination.

Authors:  Josef Finsterer
Journal:  Case Rep Infect Dis       Date:  2021-05-08

5.  Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Authors:  Merryn Voysey; Sue Ann Costa Clemens; Shabir A Madhi; Lily Y Weckx; Pedro M Folegatti; Parvinder K Aley; Brian Angus; Vicky L Baillie; Shaun L Barnabas; Qasim E Bhorat; Sagida Bibi; Carmen Briner; Paola Cicconi; Andrea M Collins; Rachel Colin-Jones; Clare L Cutland; Thomas C Darton; Keertan Dheda; Christopher J A Duncan; Katherine R W Emary; Katie J Ewer; Lee Fairlie; Saul N Faust; Shuo Feng; Daniela M Ferreira; Adam Finn; Anna L Goodman; Catherine M Green; Christopher A Green; Paul T Heath; Catherine Hill; Helen Hill; Ian Hirsch; Susanne H C Hodgson; Alane Izu; Susan Jackson; Daniel Jenkin; Carina C D Joe; Simon Kerridge; Anthonet Koen; Gaurav Kwatra; Rajeka Lazarus; Alison M Lawrie; Alice Lelliott; Vincenzo Libri; Patrick J Lillie; Raburn Mallory; Ana V A Mendes; Eveline P Milan; Angela M Minassian; Alastair McGregor; Hazel Morrison; Yama F Mujadidi; Anusha Nana; Peter J O'Reilly; Sherman D Padayachee; Ana Pittella; Emma Plested; Katrina M Pollock; Maheshi N Ramasamy; Sarah Rhead; Alexandre V Schwarzbold; Nisha Singh; Andrew Smith; Rinn Song; Matthew D Snape; Eduardo Sprinz; Rebecca K Sutherland; Richard Tarrant; Emma C Thomson; M Estée Török; Mark Toshner; David P J Turner; Johan Vekemans; Tonya L Villafana; Marion E E Watson; Christopher J Williams; Alexander D Douglas; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Andrew J Pollard
Journal:  Lancet       Date:  2020-12-08       Impact factor: 79.321

6.  Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.

Authors:  Almurtada Razok; Abdullah Shams; Ahmed Almeer; Muhammad Zahid
Journal:  Ann Med Surg (Lond)       Date:  2021-07-03

7.  Case of Guillain-Barré syndrome following COVID-19 vaccine.

Authors:  Tanveer Hasan; Mustafizur Khan; Farhin Khan; Ghanim Hamza
Journal:  BMJ Case Rep       Date:  2021-06-29

8.  Guillain-Barré syndrome after COVID-19 vaccination.

Authors:  Norma McKean; Charmaine Chircop
Journal:  BMJ Case Rep       Date:  2021-07-30

9.  A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.

Authors:  Nicola Alessandro Nasuelli; Fabiola De Marchi; Michela Cecchin; Irene De Paoli; Susanna Onorato; Roberto Pettinaroli; Giovanni Savoini; Laura Godi
Journal:  Neurol Sci       Date:  2021-07-17       Impact factor: 3.307

10.  Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine.

Authors:  Michele Trimboli; Pio Zoleo; Gennarina Arabia; Antonio Gambardella
Journal:  Neurol Sci       Date:  2021-08-04       Impact factor: 3.307
View more
  2 in total

Review 1.  Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.

Authors:  Yhojan Rodríguez; Manuel Rojas; Santiago Beltrán; Fernando Polo; Laura Camacho-Domínguez; Samuel David Morales; M Eric Gershwin; Juan-Manuel Anaya
Journal:  J Autoimmun       Date:  2022-08-24       Impact factor: 14.511

2.  Prognosis of Guillain-Barré Syndrome Linked to COVID-19 Vaccination.

Authors:  Shaun Kai Kiat Chua; Qian Ying Soh; Seyed Ehsan Saffari; Eng-King Tan
Journal:  Brain Sci       Date:  2022-05-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.